| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 74932* | 2016 |
| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Z Wang, E Klipfell, BJ Bennett, R Koeth, BS Levison, B DuGar, ... nature 472 (7341), 57-63, 2011 | 5912 | 2011 |
| Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis RA Koeth, Z Wang, BS Levison, JA Buffa, E Org, BT Sheehy, EB Britt, X Fu, ... Nature medicine 19 (5), 576-585, 2013 | 4832 | 2013 |
| Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk WHW Tang, Z Wang, BS Levison, RA Koeth, EB Britt, X Fu, Y Wu, ... New England Journal of Medicine 368 (17), 1575-1584, 2013 | 3578 | 2013 |
| A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease Nature genetics 47 (10), 1121-1130, 2015 | 2611 | 2015 |
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2271 | 2011 |
| Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk W Zhu, JC Gregory, E Org, JA Buffa, N Gupta, Z Wang, L Li, X Fu, Y Wu, ... Cell 165 (1), 111-124, 2016 | 1888 | 2016 |
| Large-scale association analysis identifies new risk loci for coronary artery disease CARDIoGRAMplusC4D Consortium, P Deloukas, S Kanoni, C Willenborg, ... Nature genetics 45 (1), 25-33, 2013 | 1795 | 2013 |
| Gut microbiota in cardiovascular health and disease WHW Tang, T Kitai, SL Hazen Circulation research 120 (7), 1183-1196, 2017 | 1570 | 2017 |
| Prognostic value of myeloperoxidase in patients with chest pain ML Brennan, MS Penn, F Van Lente, V Nambi, MH Shishehbor, RJ Aviles, ... New England Journal of Medicine 349 (17), 1595-1604, 2003 | 1515 | 2003 |
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice M Febbraio, EA Podrez, JD Smith, DP Hajjar, SL Hazen, HF Hoff, ... The Journal of clinical investigation 105 (8), 1049-1056, 2000 | 1369 | 2000 |
| Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu, E Org, X Gu, Y Huang, ... Cell 163 (7), 1585-1595, 2015 | 1335 | 2015 |
| Heart disease and stroke statistics-2012 update: A report from the American Heart Association American Heart Association Circulation 125, e12-e230, 2012 | 1321 | 2012 |
| Association between myeloperoxidase levels and risk of coronary artery disease R Zhang, ML Brennan, X Fu, RJ Aviles, GL Pearce, MS Penn, EJ Topol, ... Jama 286 (17), 2136-2142, 2001 | 1303 | 2001 |
| Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney … WHW Tang, Z Wang, DJ Kennedy, Y Wu, JA Buffa, B Agatisa-Boyle, XS Li, ... Circulation research 116 (3), 448-455, 2015 | 1187 | 2015 |
| Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation BJ Bennett, TQ de Aguiar Vallim, Z Wang, DM Shih, Y Meng, J Gregory, ... Cell metabolism 17 (1), 49-60, 2013 | 1089 | 2013 |
| 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. SL Hazen, JW Heinecke The Journal of clinical investigation 99 (9), 2075-2081, 1997 | 1056 | 1997 |
| Myeloperoxidase and cardiovascular disease SJ Nicholls, SL Hazen Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1102-1111, 2005 | 1016 | 2005 |
| Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis SJ Nicholls, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu, ... Jama 297 (5), 499-508, 2007 | 989 | 2007 |
| Apolipoprotein AI is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease L Zheng, B Nukuna, ML Brennan, M Sun, M Goormastic, M Settle, ... The Journal of clinical investigation 114 (4), 529-541, 2004 | 938 | 2004 |